Etretinate may work where acitretin fails

British Journal of Dermatology

Volumn 136, Issue 3, 1997, Pages 368-370

  Bleiker, T O ^a   Bourke, J F ^a   Graham Brown, R A C ^a   Hutchinson, P E ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ETRETIN; ETRETINATE;

ADULT; AGED; ARTICLE; CASE REPORT; DARIER DISEASE; DRY EYE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PSORIASIS;

EID: 0031052691     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1997.tb14946.x     Document Type: Article

References (19)

1. Paravincini U, Stockel PJ, MacNamara PJ et al. On the metabolism and pharmacokinetics of an oral aromatic retinoid. Ann NY Acad Sci 1981; 359: 54-67.
2. Geiger JM, Ott F, Bollag W. Clinical evaluation of an aromatic retinoid, Ro 10-1670, in severe psoriasis. Curr Ther Res 1984; 35: 735-40.
3. Kragballe K, Jansen CT, Geiger JM et al. A double blind comparison of acitretin and etretinate in the treatment of severe psoriasis. Acta Derm Venereol (Stockh) 1989; 69: 35-40.
4. Gollnick H, Bauer R, Brindley C et al. Acitretin versus etretinate in psoriasis. Clinical and pharmacokinetic results of a German multicentre study. J Am Acad Dermatol 1988; 19: 458-69.
5. Lassus A, Geiger JM. Acitretin and etretinate in the treatment of palmoplantar pustulosis: a double-blind comparative trial. Br J Dermatol 1988; 119: 755-9.
6. Christopherson J, Geiger JM. Danneskiold-Samsoe P et al. A double-blind comparison of acitretin and etretinate in the treatment of Darier's disease. Acta Derm Venereol (Stockh) 1992; 72: 150-2.
7. Blanchet-Bardon C, Nazzaro V, Rognin C et al. Acitretin in the treatment of severe disorders of keratinisation. J Am Acad Dermatol 1991; 24: 982-6.
8. Fritsch P, Honigsmann H, Jasche E. Epidermolytic hereditary palmoplantar keratoderma: report of a family and treatment with an oral aromatic retinoid. Br J Dermatol 1978; 99: 561-8.
9. Fritsch PO. Retinoids in psoriasis and disorders of keratinisation. J Am Acad Dermatol 1992; 27: S8-S14.
10. Brindley CJ. Overview of the recent clinical pharmacokinetic studies with acitretin (Ro-10-1670, Etretin). Dermatologica 1989; 178: 79-87.
11. Larsen FG, Jakobsen P, Larsen CG et al. Pharmacokinetics of etretin and etretinate during long term treatment of psoriasis patients. Pharmacol Toxicol 1988; 62: 159-65.
12. Larsen FG, Vahlquist C, Anderson E et al. Oral acitretin in psoriasis: drug and vitamin A concentrations in plasma, skin and adipose tissue. Acta Derm Venereol (Stockh) 1992; 72: 84-8.
13. Chau RC, Wyss R, Huselton CA, Weigband UW. A newly discovered xenobiotic metabolic pathway: ethyl ester formation. Life Sci 1991; 49: 169-72.
14. Geiger JM, Czarnetzki BM. Acitretin (Ro 10-1670, Etretin): overall evaluation of clinical studies. Dermatologica 1988; 176: 182-90.
15. Pilkington T, Brogden RN. Acitretin: a review of its pharmacology and therapeutic uses. Drugs 1992; 43: 597-627.
16. Vane FM, Bugge CJL, Rodriguez LC. Identitication of etretinate metabolites in human bile. Drug Metab Dispos 1989; 17: 275-9.
17. Vane FM, Bugge CJL, Rodriguez LC. Identilication of etretinate metabolites in human blood. Drug Metab Dispos 1989; 17: 280-5.
18. 14C) acitretin in humans following oral administration. Drug Metab Dispos 1994; 22: 211-15.
19. Orfanos CE, Retinoide: der neue Stand Erhaltingstherapie. Resorpionsstorungen bei 'non-responders'. Haurtarzt 1989; 40: 123-9.